SPH Updated preliminary sales revenue data for H1 2026
Sofia, Bulgaria, July 22, 2026 – “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) pursuant to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), announces that for the period from the beginning of 2026, the Company achieved sales growth of 45%, including a 3% decrease in domestic sales and sales growth of 74% in export.
| Data | Tytuł | Kurs | Zmiana |
|---|
2026-08-20 | SPH Preliminary sales revenue data for July 2026 | 7,92 | +0,51 |
2026-08-20 | SPH Preliminary sales revenue data for July 2026 | 7,92 | +0,25 |
2026-08-20 | SPH Updated preliminary sales revenue data for July 2026 | 7,92 | +0,25 |
2026-08-18 | SPH Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for a pledge of shares of "Sopharma" AD on 17.08.2026 | 7,52 | 0,00 |
2026-08-18 | SPH Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for a pledge of shares of "Sopharma" AD | 7,52 | 0,00 |
2026-07-30 | SPH Conclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS | 7,18 | 0,00 |
2026-07-30 | SPH Individual financial report according to IFRS as at 30 June 2026 | 7,18 | 0,00 |
2026-07-22 | SPH Updated preliminary sales revenue data for H1 2026 | 7,56 | +5,29 |
2026-07-20 | SPH Preliminary sales revenue data for June 2026 | 7,56 | 0,00 |
2026-07-06 | SPH Notification on the conclusion of a transaction under the application of Article 114, paragraph 2 of the LPOS | 7,70 | 0,00 |
